This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dex One Achieves Quarterly Ad Sales Guidance And Reports Third Quarter Results

Stocks in this article: DEXO

Net income, cash flow from operations and total debt (including fair value discount) in the third quarter were $22 million, $82 million and $2,552 million, respectively.

Mockett continued, “We marginally exceeded third quarter ad sales guidance despite both the secular pressure on our print products and difficult local business conditions. We are making steady progress towards our goal of returning to growth, albeit more slowly than we originally expected.”

Newly appointed CFO Gregory W. Freiberg added, “Third quarter financial performance was in line with expectations, which gives us confidence to affirm our full year guidance. We remain on track to achieve our 2011 cost reduction target. We also continue to reduce net debt and look for other ways to increase balance sheet flexibility, including obtaining credit agreement amendments to allow us to repurchase debt below par.”

2011 OUTLOOK

The company announced fourth quarter ad sales guidance and affirmed its previously issued full year guidance.

       

Metric (dollars in millions)

   

Guidance

Fourth Quarter

Year over year change in advertising sales     (12.5%) to (13.5%)
       

Full Year

Net revenue     $1,475 to $1,500
Adjusted EBITDA (1)     $625 to $650
Free cash flow (1)     $375 to $400
Net debt - eliminating fair value discount (1)     $2,350




2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs